Interferon regulatory factor 3 activates p53-dependent cell growth inhibition

Cancer Letters

Volumn 242, Issue 2, 2006, Pages 215-221

  Kim, Tae Kyung ^a   Lee, Joong Seob ^a   Jung, Ji Eun ^a   Oh, Se Yeong ^a   Kwak, Sungwook ^a   Jin, Xun ^a   Lee, Soo Yeon ^a   Lee, Jang Bo ^b   Chung, Yong Gu ^b   Choi, Young Ki ^c   You, Seungkwon ^a   Kim, Hyunggee ^a  

^a Sanghuh College of Life Sciences   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

BJ; Cell proliferation; IFN ; IRF3; p53; Senescence

Indexed keywords

BETA GALACTOSIDASE; INTERFERON REGULATORY FACTOR 3; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL AGING; CELL DEATH; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SOMATIC CELL;

ANIMALS; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERFERON REGULATORY FACTOR-3; MICE; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33749237825     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.11.003     Document Type: Article

References (24)

1. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961) 585-621
2. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92 (1995) 9363-9367
3. Kim H., You S., Farris J., Kong B.W., Christman S.A., Foster L.K., et al. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells. Exp. Cell Res. 272 (2002) 199-208
4. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
5. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
6. Shay J.W., Pereira-Smith O.M., and Wright W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196 (1991) 33-39
7. Sherr C.J., and DePinho R.A. Cellular senescence: mitotic clock or culture shock?. Cell 102 (2000) 407-410
8. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. A potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
9. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
10. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., et al. A BH3-Only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288 (2000) 1053-1058
11. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
12. Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer 3 (2003) 102-109
13. Servant M.J., ten Oever B., LePage C., Conti L., Gessani S., Julkunen I., et al. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276 (2001) 355-363
14. tenOever B.R., Servant M.J., Grandvaux N., Lin R., and Hiscott J. Recognition of the measles viral nucleocapsid as a mechanism of IRF-3 activation. J. Virol. 76 (2002) 3659-3669
15. Karpova A.Y., Trost M., Murray J.M., Cantley L.C., and Howley P.M. Interferon regulatory factor-3 is an in vivo target of DNA-PK. Proc. Natl Acad. Sci. USA 99 (2002) 2818-2823
16. Duguay D., Mercier F., Stagg J., Martineau D., Bramson J., Servant M., et al. In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors. Cancer Res. 62 (2002) 5148-5152
17. Kim T.Y., Lee K.H., Chang S., Chung C., Lee H.W., Yim J., et al. Oncogenic potential of a dominant negative mutant of interferon regulatory factor 3. J. Biol. Chem. 278 (2003) 15272-15278
18. Doyle S.E., Vaidya S.A., O'Connell R., Dadgostar H., Dempsey P.W., Wu T.-T., et al. IRF3 and NF-kB mediate a TLR4-specific gene program. Immunity 17 (2002) 251-263
19. Takaoka A., Hayakawa S., Yanai H., Stoiber D., Negishi H., Kikuchi H., et al. Integration of IFN-α/β signalling to p53 responses in tumor suppression and antiviral defense. Nature 424 (2003) 516-523
20. Weber J.D., Taylor L.J., Roussel M.F., Sherr C.J., and Bar-Sagi D. Nucleolar arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1 (1999) 20-26
21. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., et al. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2 (2000) 730-736
22. Freeman D.J., Li A.G., Wei G., Li H.H., Kertesz N., Lesche R., et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3 (2003) 117-130
23. Bernardi R., Scaglioni P.P., Bergmann S., Horn H.F., Vousden K.H., and Pandolfi P.P. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. Nat. Cell Biol. 6 (2004) 665-672
24. Dornan D., Wertz I., Shimizu H., Arnott D., Frantz G.D., Dowd P., et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429 (2004) 86-92